Personalized medicine for psychiatry
The Genomind Genecept Assay® is a genetic test used to inform clinicians’ decision-making when prescribing medications and treatments for psychiatric conditions.
Genetic results provide one piece of evidence for the heterogeneity observed in medication response. They offer information about the likelihood that a patient will respond to a medication therapy and/or experience adverse events or drug interactions. Treatment decisions informed by these genetic results can offer a personalized treatment plan to objectively address presenting symptoms and side effects. The genes analyzed in the Genomind Genecept Assay are associated with a wide range of psychotropic medications and can help to inform treatment plans for depression, anxiety, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, post traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse.
Watch a short overview
This personalized, data-driven approach, which is pain-free and simple to perform, can reduce the expense and struggle of finding the right treatment by trial and error.
A simple, non-invasive cheek swab test that can be administered quickly and easily in your office.
A complimentary consultation with experts in the field of psychopharmacogenetics is available with each report.
The results report provides clear clinical implications, and can eliminate some of the trial and error during treatment planning.
Please know that your work is making a huge difference for my patients. We have made successful medication changes in about 90% of the patients who have undergone the Genecept Assay® to date in my practice.